Rosaria Greco Selected Research

N(G)-iminoethylornithine

1/2018	Endothelial nitric oxide synthase inhibition triggers inflammatory responses in the brain of male rats exposed to ischemia-reperfusion injury.
2/2011	IkappaB-alpha expression following transient focal cerebral ischemia is modulated by nitric oxide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosaria Greco Research Topics

Disease

30	Migraine Disorders (Migraine) 07/2022 - 10/2005
25	Pain (Aches) 07/2022 - 01/2003
16	Hyperalgesia 07/2022 - 01/2003
7	Stroke (Strokes) 06/2021 - 10/2014
6	Brain Ischemia (Cerebral Ischemia) 01/2021 - 02/2011
5	Ischemic Stroke 06/2021 - 01/2007
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 07/2012
4	Headache (Headaches) 11/2017 - 07/2010
3	Neuroinflammatory Diseases 01/2018 - 07/2012
3	Ischemia 07/2012 - 01/2007
2	Neuralgia (Stump Neuralgia) 10/2018 - 09/2018
2	Reperfusion Injury 01/2018 - 07/2012
2	Parkinson Disease (Parkinson's Disease) 01/2017 - 09/2015
2	Hypertension (High Blood Pressure) 03/2016 - 10/2014
2	Diabetic Foot 03/2016 - 10/2014
2	Chronic Limb-Threatening Ischemia 10/2014 - 02/2014
1	Inflammation (Inflammations) 07/2022
1	Prescription Drug Overuse 01/2021
1	Cluster Headache (Cluster Headaches) 01/2019
1	Brain Infarction 01/2019
1	Thrombosis (Thrombus) 01/2018
1	Osteomyelitis 03/2016
1	Abscess 03/2016
1	Renal Insufficiency (Renal Failure) 03/2016
1	Ulcer 03/2016
1	Infections 03/2016
1	Gangrene 03/2016

Drug/Important Bio-Agent (IBA)

23	Nitroglycerin (Dynamite)FDA LinkGeneric 07/2022 - 01/2003
13	EndocannabinoidsIBA 07/2022 - 07/2010
13	Formaldehyde (Formol)FDA Link 01/2021 - 01/2003
7	Calcitonin Gene-Related PeptideIBA 07/2022 - 09/2017
6	anandamide (arachidonylethanolamide)IBA 01/2021 - 04/2011
6	Pharmaceutical PreparationsIBA 01/2021 - 01/2003
5	CytokinesIBA 07/2022 - 01/2003
5	LipidsIBA 07/2022 - 07/2010
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2017 - 03/2006
4	EnzymesIBA 03/2022 - 01/2003
4	Messenger RNA (mRNA)IBA 06/2021 - 01/2015
4	Biomarkers (Surrogate Marker)IBA 06/2021 - 07/2012
3	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 07/2022 - 01/2021
3	Monoclonal AntibodiesIBA 03/2022 - 12/2020
3	CannabinoidsIBA 01/2021 - 07/2010
3	Glutamic Acid (Glutamate)FDA Link 07/2018 - 03/2006
3	Analgesics (Analgesic Drugs)IBA 01/2018 - 01/2003
3	Receptor for Advanced Glycation End ProductsIBA 04/2017 - 07/2012
3	Estrogens (Estrogen)FDA Link 01/2017 - 10/2012
3	ProstaglandinsIBA 01/2007 - 01/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2022 - 06/2021
2	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 07/2022 - 01/2020
2	Substance PIBA 07/2022 - 09/2017
2	palmidrolIBA 03/2022 - 01/2021
2	NeuropeptidesIBA 01/2021 - 07/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2011
2	URB937IBA 01/2021 - 01/2020
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021 - 01/2021
2	CB2 Cannabinoid ReceptorIBA 01/2021 - 03/2014
2	AntibodiesIBA 10/2020 - 12/2014
2	AnkyrinsIBA 10/2018 - 09/2017
2	N(G)-iminoethylornithineIBA 01/2018 - 02/2011
2	Monoacylglycerol LipasesIBA 01/2018 - 12/2015
2	Nitric Oxide Synthase (NO Synthase)IBA 04/2017 - 03/2006
2	Insulin (Novolin)FDA Link 03/2016 - 10/2014
2	Protein Isoforms (Isoforms)IBA 12/2014 - 07/2012
2	NF-kappa B (NF-kB)IBA 02/2011 - 10/2005
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 07/2022
1	Peptides (Polypeptides)IBA 07/2022
1	CarbamatesIBA 07/2022
1	AmidesIBA 07/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 07/2022
1	Interleukin-4 (Interleukin 4)IBA 06/2021
1	InterleukinsIBA 06/2021
1	Interleukin-10 (Interleukin 10)IBA 06/2021
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2021
1	Type A Botulinum Toxins (Botox)FDA Link 01/2021
1	iodopravadoline (AM 630)IBA 01/2021
1	AM 251 (AM251)IBA 01/2021
1	incobotulinumtoxinA FDA Link 01/2021
1	Glycerol (Glycerine)FDA LinkGeneric 01/2021
1	HydrolasesIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 10/2020
1	erenumabIBA 10/2020
1	Proto-Oncogene Proteins c-fos (FRAs)IBA 01/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2019
1	NitratesIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Volatile Oils (Essential Oils)IBA 09/2018
1	gamma-Aminobutyric Acid (GABA)IBA 07/2018
1	Topiramate (Topamax)FDA LinkGeneric 07/2018
1	Immunomodulating AgentsIBA 01/2018
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2018
1	URB602IBA 01/2018
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2018
1	Kynurenic Acid (Kynurenate)IBA 11/2017
1	TRPA1 Cation ChannelIBA 09/2017

Therapy/Procedure

7	Therapeutics 01/2021 - 10/2005
2	Surgical Amputation (Amputations) 03/2016 - 10/2014
1	Injections 01/2021
1	Aromatherapy 09/2018
1	Mechanical Thrombolysis 01/2018
1	Renal Dialysis (Hemodialysis) 03/2016